![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 401/04 | (2006.01) |
C07D 401/14 | (2006.01) | ||
C07D 405/12 | (2006.01) | ||
C07D 405/14 | (2006.01) | ||
C07D 417/12 | (2006.01) | ||
A61K 31/506 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2261223 |
(13) | Kind of document | T |
(96) | European patent application number | 10173136.2 |
Date of filing the European patent application | 2007-01-22 | |
(97) | Date of publication of the European application | 2010-12-15 |
(45) | Date of publication and mention of the grant of the patent | 2013-06-12 |
(46) | Date of publication of the claims translation | 2013-10-25 |
(30) | Number | Date | Country code |
760789 P | 2006-01-20 | US |
(72) |
Burger, Matthew, US
Ni, Zhi-jie, US
Pecchi, Sabina, US
Atallah, Gordana, US
Bartulis, Sarah, US
Frazier, Kelly, US
Smith, Aaron, US
Verhagen, Joelle, US
Zhang, Yanchen, US
Wagman, Allan, US
Ng, Simon, US
Pfister, Keith, US
Poon, Daniel, US
Louie, Alicia, US
Pick, Teresa, US
Barsanti, Paul, US
Iwanowicz, Edwin, US
Fantl, Wendy, US
Hendrickson, Thomas, US
Knapp, Mark, US
Meritt, Hanne, US
Voliva, Charles, US
Wiesmann, Marion, US
Xin, Xiahua, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirimidino dariniai, naudojami kaip pi-3 kinazės inhibitoriai |
Pyrimidine derivatives used as pi-3 kinase inhibitors |
Payment date | Validity (years) | Amount | |
2024-01-09 | 18 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2025-01-22 |